Michael and Peggy Cain Dean's Enrichment Endowment Fund

Outside view of Jacobs School of Medicine.

This fund facilitates key priorities throughout the Jacobs School of Medicine and Biomedical Sciences.

Michael E. Cain, MD.

Dean Michael Cain

Established by Michael and Peggy Cain, the Dean’s Enrichment Endowment Fund provides a variety of resources that help the medical school achieve its priorities, while also inspiring others to invest in the school.

Michael E. Cain, MD, is Vice President for Health Sciences and Dean of the Jacobs School of Medicine and Biomedical Sciences. His many accomplishments include leading the efforts to rebuild and modernize the Jacobs School in an effort to improve the educational experience for students.

In his health sciences role, Dean Cain leads the university’s five health sciences schools. He also serves as professor of medicine and professor of biomedical engineering. Dean Cain has been awarded the UB President’s Medal, which is given in recognition of extraordinary service to the university.

Peggy Cain, herself a biomedical researcher, has also championed the efforts to sustain and advance the medical school, working tirelessly to serve the UB community. Her ongoing support has helped support the training of physicians and scientists, facilitate bench and clinical research, and foster collaborations with the local medical community.

Make a Difference Now

Other Jacobs School of Medicine and Biomedical Sciences Funds

News from the Jacobs School of Medicine and Biomedical Sciences

  • Residents Present at Meeting for International Society
    2/12/20

    Trainees in the orthopaedic residency have presented their research at the annual meeting for the Orthopaedic Research Society.

  • Researchers Urge Mucosal Immunity Study for COVID-19
    12/15/20

    Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.

  • Gomez Completes Genomic Analysis of Shiga-Toxin E-Coli
    11/2/20

    Oscar G. Gomez, MD, PhD, associate professor of pediatrics and chief of its Division of Infectious Diseases, has completed the genomic analysis of a specific strain of Shiga-toxin E. coli (STEC) that can cause severe disease outbreaks and is increasingly common. 

  • Predicting the Path of COVID-19 From Wuhan to WNY
    10/21/20

    Jennifer A. Surtees, PhD, associate professor of biochemistry, is leading an effort to track the genomics of COVID-19 in Western New York.

  • Team Alice Evaluating Tools for Deprescribing Discussions
    11/25/20

    Team Alice, an initiative of the University at Buffalo’s Center for Successful Aging, has been awarded a $60,000 grant from the U.S. Deprescribing Research Network (USDeN) to evaluate an educational video designed to encourage patient/caregiver-initiated deprescribing conversations with doctors and to evaluate its impact on medication use.

  • 17 Faculty Members Join 6 Medical School Departments
    9/16/20

    Seventeen faculty members with a variety of clinical and research experience — representing six medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.

  • Partnering on Project for Test Predicting Severe COVID-19
    6/18/20

    The University at Buffalo is joining forces with Roswell Park Comprehensive Cancer Center and other regional and national health and research leaders to develop blood tests that uncover hidden information in the cells of those exposed to the novel coronavirus to determine which patients will develop severe symptoms.